Detalhe da pesquisa
1.
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
Oncologist
; 28(9): 827-e822, 2023 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37104870
2.
Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.
Ann Surg Oncol
; 30(6): 3479-3488, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36792768
3.
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Invest New Drugs
; 40(6): 1306-1314, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36264382
4.
Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study.
Ann Surg
; 274(6): e1153-e1161, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31913871
5.
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy.
Oncologist
; 25(8): 669-679, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31943525
6.
Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Oncologist
; 24(4): 463-474, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30355775
7.
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
N Engl J Med
; 374(3): 211-22, 2016 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-26789870
8.
Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.
HPB (Oxford)
; 21(7): 883-890, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30723062
9.
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.
Oncologist
; 23(1): 16-24, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29038234
10.
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med
; 372(26): 2509-20, 2015 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-26028255
11.
Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.
Ann Surg Oncol
; 25(7): 1880-1888, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29667116
12.
BIOCHEMICAL RESPONSES IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH NEUROENDOCRINE TUMORS: POOLED ANALYSIS OF 2 PHASE 3 TRIALS.
Endocr Pract
; 2018 Aug 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30084687
13.
LANREOTIDE THERAPY IN CARCINOID SYNDROME: PROSPECTIVE ANALYSIS OF PATIENT-REPORTED SYMPTOMS IN PATIENTS RESPONSIVE TO PRIOR OCTREOTIDE THERAPY AND PATIENTS NAÏVE TO SOMATOSTATIN ANALOGUE THERAPY IN THE ELECT PHASE 3 STUDY.
Endocr Pract
; 24(3): 243-255, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29547049
14.
EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
Endocr Pract
; 22(9): 1068-80, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27214300
15.
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
Cancer
; 121(7): 1128-37, 2015 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25538019
16.
Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer.
J Vasc Interv Radiol
; 25(7): 1085-93, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24457263
17.
Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.
HPB (Oxford)
; 16(4): 304-11, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23991643
18.
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
J Immunother Cancer
; 12(2)2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38355279
19.
Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.
Cancer
; 119(24): 4223-30, 2013 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24105075
20.
Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
Ann Surg Oncol
; 20(5): 1631-8, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23149854